In Figure S15A (Supporting Information), compared with PBS, PD‐L1 level on tumor cells increased by ≈6.7% after EB@MPCM therapy, but was down‐regulated after EB@MPCM+αPD‐L1 or EB@MPCM+Laser treatment, especially in EB@MPCM+Laser group. The gene discussed is CD274; the disease is neoplasm.